Webinar | April 18, 2024

Optimizing Perfusion Parameters For Intensified Production Of CAR-T Cells In The Ambr 250 High Throughput Bioreactor

Source: Sartorius

Achieving therapeutic doses in CAR-T cell therapies represents the longest phase of manufacturing. In this webinar, we explore scalable expansion processes designed to help meet growing demand.

access the Webinar!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online